Positive results for rituximab in patients with neuropsychiatric SLE

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Rheumatology | 2007年 / 3卷 / 6期
关键词：
D O I：
10.1038/ncprheum0492
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：311 / 312
页数：1
相关论文
共 50 条
  • [21] Neurometabolic studies in neuropsychiatric SLE
    Handa, R
    Sahota, P
    Jagganathan, NR
    Bal, CS
    Gulati, MS
    Tripathi, BM
    Wali, JP
    JOURNAL OF RHEUMATOLOGY, 2001, 28 : 44 - 44
  • [22] Rituximab affects both humoral and cellular immunity in patients with SLE
    Nature Clinical Practice Rheumatology, 2007, 3 (4): : 193 - 194
  • [23] Positive results for anifrolumab in phase III SLE trial
    Onuora, Sarah
    NATURE REVIEWS RHEUMATOLOGY, 2020, 16 (03) : 125 - 125
  • [24] Patients with NPSLE experience poorer HRQoL and more fatigue than SLE patients with no neuropsychiatric involvement, irrespective of neuropsychiatric activity
    Nikolopoulos, Dionysis
    Cetrez, Nursen
    Lindblom, Julius
    Palazzo, Leonardo
    Enman, Yvonne
    Parodis, Ioannis
    RHEUMATOLOGY, 2024, 63 (09) : 2494 - 2502
  • [25] DYNAMICS OF B LYMPHOCYTE SUBSETS IN SLE PATIENTS TREATED WITH RITUXIMAB
    Mesnyankina, A. A.
    Aleksandrova, E. N.
    Soloviev, S. K.
    Aleksankin, A. P.
    Glukhova, S. I.
    Novikov, A. A.
    Suponitskaya, E. V.
    Aseeva, E. A.
    Nasonov, E. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 289 - 289
  • [26] EFFECT OF RITUXIMAB ON DIFFERENT ISOTYPES OF SERUM IMMUNOGLOBULINS IN PATIENTS WITH SLE
    Reddy, Venkat
    Martinez, Lina
    Isenberg, David
    Cambridge, Geraldine
    Leandro, Maria
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : A53 - A53
  • [27] INEFFICACY OF BELIMUMAB IN SLE PATIENTS WHO LOSE RESPONSE TO RITUXIMAB
    Ul Hassan, Sabih
    Yusof, Mohammad Y. M.
    Dutton, Katherine
    Dass, Shouvik
    Vital, Edward
    RHEUMATOLOGY, 2019, 58 : 93 - 93
  • [28] LOW IGM IN A COHORT OF PATIENTS WITH SLE PRIOR TO RITUXIMAB ERA
    Shahbaz-Samavi, M.
    Hewitt, J.
    Haque, S.
    Shelmerdine, J.
    Ahmad, Y.
    Bruce, I. N.
    RHEUMATOLOGY, 2010, 49 : I121 - I122
  • [29] LONG-TERM EFFICACY OF RITUXIMAB IN PATIENTS WITH REFRACTORY SLE
    Tsanyan, M.
    Soloviev, S.
    Torgashina, A.
    Aleksandrova, E.
    Radenska-Lopovok, S.
    Nikolaeva, E.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 527 - 527
  • [30] Positive results for anifrolumab in phase III SLE trial
    Sarah Onuora
    Nature Reviews Rheumatology, 2020, 16 : 125 - 125
12345